HONG KONG – Chinese authorities will participate in a cross-agency campaign to regularly publish a blacklist of companies and share information among multiple authorities to improve product safety of drugs and medical devices.
HONG KONG – Chinese authorities will participate in a cross-agency campaign to regularly publish a blacklist of companies and share information among multiple authorities to improve product safety of drugs and medical devices.
HONG KONG – China's pharmaceutical industry is undergoing a painful reform as regulations tighten, in particular a recent push by the CFDA to clamp down on untrustworthy clinical trial data.
HONG KONG – With rapidly expanding on-the-ground operations, biotechnology giant Amgen Inc. is looking to strengthen its presence in Asian markets and to build more market share.
HONG KONG – With rapidly expanding on-the-ground operations, biotechnology giant Amgen Inc. is looking to strengthen its presence in Asian markets and to build more market share.
HONG KONG – In the wake of a couple of incidents that have highlighted holes in China's drug traceability and distribution systems, the country's drug regulation has put forward a series of regulatory revisions.
